Pulmonary Arterial Hypertension Due to Talc Granulomatosis Following Intravenous Use of Oral Medications: A Report of a Rare Case
Abstract
Pulmonary talcosis is a rare granulomatous lung disease resulting from the intravenous injection of crushed oral tablets containing insoluble excipients such as talc, microcrystalline cellulose, and crospovidone. These substances embolize within the pulmonary vasculature, provoking granulomatous inflammation that may progress to pulmonary arterial hypertension (PAH). We present a case report of a 25-year-old male who presented with acute-onset shortness of breath, chest pain, dry cough, fatigue, and palpitations. On examination, he was dyspneic and tachypneic and exhibited bilateral basal inspiratory crackles with signs of right heart strain. Imaging revealed elevated right ventricular pressures and computed tomography (CT) findings of centrilobular nodules with sparing of the subpleural regions and fissures, characteristic of talc granulomatosis. A detailed history revealed longstanding intravenous polysubstance abuse over five years, including methamphetamine, tapentadol, and cocaine, likely contributing to his pulmonary pathology. Based on clinical, imaging, and echocardiographic findings, a diagnosis of pulmonary hypertension secondary to talcosis was established. The patient was managed with supplemental oxygen, antiplatelet therapy, and oral sildenafil, resulting in symptomatic improvement, and was strongly advised to cease intravenous drug use. A lung biopsy was planned for histological confirmation. This case report aims to emphasize the importance of recognizing…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Drug repositioning: a brief overview
- Cyclic nucleotide phosphodiesterases in Drosophila melanogaster
- Time-resolved in silico modeling of fine-tuned cAMP signaling in platelets: feedback loops, titrated phosphorylations and pharmacological modulation
- Current View on Green Tea Catechins Formulations, Their Interactions with Selected Drugs, and Prospective Applications for Various Health Conditions
- In silico Structure-based Identification of Novel Acetylcholinesterase Inhibitors Against Alzheimer’s Disease
- Development and In Vitro Evaluation of Controlled Release Viagra® Containing Poloxamer-188 Using Gastroplus™ PBPK Modeling Software for In Vivo Predictions and Pharmacokinetic Assessments
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.